The Trial Lawyer's Journal

TLJ Small Logo
Close
Group 39053677
Share Your Story with Trial Lawyer’s Journal
Trial Lawyer’s Journal is built on the voices of trial lawyers like you. Share your journey, insights, and experiences through articles, interviews, and our podcast, Celebrating Justice.
Stay Updated
Sign up for our newsletter to get the latest from TLJ.



    Supreme Court Rules NJ Transit Must Face Injury Lawsuits in Other States — What It Means for Accident Victims

    A conceptual illustration depicting the U.S. Supreme Court delivered a major win for plaintiffs in Galette v. New Jersey Transit Corp., unanimously rejecting a sovereign immunity defense that has derailed numerous injury cases before they could be adjudicated on the merits.
    What did the Supreme Court decide in Galette v. New Jersey Transit Corporation?

    On March 4, 2026, the Supreme Court unanimously ruled that NJ Transit is not an “arm of the state” of New Jersey and therefore cannot claim New Jersey’s sovereign immunity to avoid being sued in the courts of other states. Writing for a unanimous Court, Justice Sotomayor found that NJ Transit’s corporate structure, its power to sue and be sued, and New Jersey’s formal non-liability for its debts all established it as a legally independent entity. As a result, lawsuits filed by people injured by NJ Transit vehicles in states like New York and Pennsylvania can proceed in those states’ courts rather than being dismissed on immunity grounds. The ruling also sets a national standard for how courts should evaluate similar immunity claims brought against other state-created corporations and quasi-public agencies.

    No. This ruling only resolved a legal threshold question about whether NJ Transit can be sued in other states at all — it did not decide who was at fault in any particular accident. To prevail in a negligence lawsuit, an injured person must still prove that NJ Transit owed them a duty of care, that NJ Transit breached that duty through negligent conduct, and that the breach caused their injuries and resulting damages. The Supreme Court’s decision clears the courtroom door; what happens inside the courtroom still depends entirely on the specific facts and evidence in each individual case.

    It depends. Statutes of limitations — the legal deadlines for filing a lawsuit — vary by state and by type of claim, and some states impose special notice requirements for claims against public or quasi-public entities. The Supreme Court’s ruling does not extend or revive time limits that may have already expired. If your accident happened some time ago, you should consult a personal injury attorney as soon as possible to determine whether your claim is still timely and whether any prior dismissal on immunity grounds can be challenged or refiled in light of this decision.

    In a negligence case against NJ Transit, relevant evidence typically includes the official accident or incident report, surveillance footage from the bus or nearby traffic and business cameras, witness statements and contact information, your complete medical records documenting your injuries and treatment, photographs of the accident scene and any visible injuries, any communications you had with NJ Transit or its insurers after the accident, and maintenance or inspection records for the vehicle involved obtainable through the discovery process. Evidence can disappear quickly — surveillance footage is often overwritten within days — so preserving and documenting everything as early as possible is critical to any claim.

    On March 4, 2026, a unanimous Court ruled in Galette v. New Jersey Transit Corporation that NJ Transit is not an “arm of the state” of New Jersey and therefore cannot hide behind New Jersey’s sovereign immunity to escape lawsuits filed in other states. The decision resolves a split between the highest courts of New York and Pennsylvania, clears the way for injured people to pursue their negligence claims in the state where they were hurt, and resets the national standard for when state-created corporations can — and cannot — claim immunity from suit.

    What Happened: Two Crashes, Two Victims, One Major Legal Question

    This case began with two real people who were seriously hurt by NJ Transit buses operating far from New Jersey’s borders.

    In 2017, Jeffrey Colt was crossing 40th Street in Midtown Manhattan when an NJ Transit bus struck him and knocked him to the ground. A year later, in 2018, Cedric Galette was a passenger in a car traveling down Market Street in Philadelphia when an NJ Transit bus crashed into the vehicle. Both men suffered serious injuries. Both sued NJ Transit for negligence — Colt in New York courts, Galette in Pennsylvania courts.

    NJ Transit did not dispute the accidents or deny being involved. Instead, the agency moved to have both cases thrown out entirely, arguing that it qualifies as an “arm of the state” of New Jersey — which would entitle it to share in New Jersey’s sovereign immunity and avoid being sued in other states’ courts without consent. The New York Court of Appeals rejected that argument and allowed Colt’s case to proceed. The Pennsylvania Supreme Court sided with NJ Transit and dismissed Galette’s case outright. That direct conflict between two state supreme courts is exactly the kind of legal uncertainty the U.S. Supreme Court exists to resolve. The Court agreed to hear both cases and consolidated them for argument on January 14, 2026.

    The plaintiff in the New York case was represented before the Supreme Court by Sullivan Papain Block McManus Coffinas & Cannavo P.C., a prominent New York-based plaintiff’s personal injury firm whose advocacy in this case drew recognition from across the legal community.

    • Jeffrey Colt was struck by an NJ Transit bus while crossing a Midtown Manhattan street in 2017
    • Cedric Galette was injured in a Philadelphia car crash caused by an NJ Transit bus in 2018
    • Both men sued for negligence in their home states; NJ Transit sought dismissal in both cases
    • New York’s top court allowed the lawsuit to proceed; Pennsylvania’s top court dismissed it
    • The Supreme Court consolidated both cases and heard argument in January 2026 to resolve the conflict

    The Legal Battle: What Is “Sovereign Immunity” and Why Did It Matter Here?

    Sovereign immunity is a legal doctrine with deep historical roots. The basic idea is that a state government cannot be sued in another state’s courts without its consent. It protects state treasuries and preserves states’ ability to make their own decisions about how to spend limited public resources.

    But sovereign immunity belongs to the state itself — not to every entity the state creates. The legal question in these cases was whether NJ Transit counts as an “arm of the state,” meaning it gets to share in New Jersey’s immunity, or whether it is a legally separate corporation that can be held accountable in court like any other organization.

    NJ Transit argued it deserved immunity for several reasons. It was created by the New Jersey Legislature. It serves essential public transportation functions. It receives substantial state funding — historically anywhere from 15% to 46% of its annual operating budget over 35 years. And the state exercises significant control over it, including the Governor’s power to appoint and remove board members and veto board actions.

    The injured plaintiffs argued the opposite: that NJ Transit was created as a corporation with all the hallmarks of separate legal identity — the power to sue and be sued in its own name, make its own contracts, hold its own property, and incur its own debts. And critically, under New Jersey law, the state is not formally responsible for NJ Transit’s debts or judgments. NJ Transit itself conceded that point before the Supreme Court.

    A group of 23 states filed a friend-of-the-court brief urging the justices to adopt a rule that a state’s own labeling of an entity — such as calling it an “instrumentality of the state” — should be the end of the inquiry. The Court declined to adopt that approach, finding it circular and unworkable.

    • Sovereign immunity protects states from being sued without their consent, including in other states’ courts
    • The key legal question was whether NJ Transit is an “arm of the state” entitled to share that immunity
    • NJ Transit pointed to state control, public functions, and state funding as evidence it should be immune
    • The plaintiffs pointed to NJ Transit’s corporate structure, independent legal identity, and the state’s formal non-liability for its debts
    • Twenty-three states filed amicus briefs urging a rule that would favor state-defined labels — a position the Court unanimously rejected

    The Supreme Court’s Ruling: Corporate Structure Wins, Immunity Claim Fails

    Justice Sotomayor wrote the opinion for a unanimous Court, issued March 4, 2026.

    The Court held that the most important question in any arm-of-the-state analysis is whether the state structured the entity as a legally separate organization responsible for its own judgments — or whether the state would itself be on the hook if a judgment were entered. When a state creates a corporation with traditional corporate powers, courts should presume that the entity enjoys all the advantages and disadvantages of separate legal status, including the fact that it is no longer part of the state itself.

    NJ Transit, the Court found, fits that description clearly. New Jersey created it as a “body corporate and politic with corporate succession.” It can sue and be sued. It enters its own contracts. It holds its own property. It sets and collects its own fares and raises its own funds through gifts, grants, and loans. And New Jersey law explicitly provides that no debt or liability of NJ Transit shall be deemed a debt or liability of the state. NJ Transit conceded before the Court that New Jersey is not formally liable for its debts.

    The fact that the state labeled NJ Transit an “instrumentality of the state” didn’t change the outcome. Sotomayor noted that the term lacks the historical weight of the corporate form, and that other New Jersey laws — including the New Jersey Tort Claims Act and the Contractual Liability Act — actually exclude NJ Transit from the definition of “State” because it has sue-and-be-sued authority. The law calls it an instrumentality on one page, then excludes it from the definition of the state on another. That kind of internal contradiction in state law, the Court found, cannot be resolved by simply deferring to the label the state preferred.

    On state control, the Court acknowledged New Jersey’s significant oversight of NJ Transit: the Governor can appoint and remove board members, a state cabinet official chairs the board, and the Governor can veto board actions. But the Court cautioned against treating control as decisive. Every state-created entity is ultimately subject to some state oversight; that doesn’t make them all arms of the state. Cities, counties, and school boards all operate under state oversight, and none share in state sovereign immunity. The same logic applied here.

    • Justice Sotomayor wrote for a unanimous nine-justice Court, decided March 4, 2026
    • Legal separateness and formal financial independence are the central factors in arm-of-the-state analysis
    • NJ Transit’s corporate structure, sue-and-be-sued authority, and the state’s formal non-liability for its debts all weighed against immunity
    • The “instrumentality” label in NJ Transit’s founding statute did not overcome its corporate identity under settled law
    • State control over NJ Transit, while substantial, was not dispositive and did not convert the agency into a state arm

    What This Means for Injured People, Their Families, and the Future of Transit Accountability

    This ruling has real, immediate consequences for anyone hurt by an NJ Transit bus, train, or light rail vehicle outside of New Jersey.

    Before this decision, NJ Transit could — and did — argue in courts across the region that sovereign immunity required dismissal of negligence claims. If you were injured in New York or Pennsylvania, NJ Transit’s position was essentially: you can’t sue us here. The Pennsylvania Supreme Court had accepted that argument and dismissed Galette’s case without ever reaching the question of whether NJ Transit drove negligently. Now the Supreme Court has rejected that approach unanimously.

    People injured by NJ Transit in New York, Pennsylvania, or anywhere else the agency operates can now sue in their home state courts without worrying that a case will be dismissed on immunity grounds. That matters enormously for practical reasons — pursuing a claim in your own state means access to local attorneys who know the courts, proximity to witnesses and evidence, and the ability to work within a legal system that is already accessible to you.

    The reaction from the plaintiff’s bar was immediate. “Today’s U.S. Supreme Court decision is a major victory for injured people and for accountability under the law,” said Andrew Finkelstein, President of the New York State Trial Lawyers Association. “We commend Sullivan Papain Block McGrath Coffinas & Cannavo P.C. for their outstanding advocacy in this case. The Court made clear that corporate entities created by states cannot hide behind sovereign immunity to avoid responsibility for their negligence. This ruling ensures that large public corporations must answer in court when their conduct harms the public.”

    The ruling’s reach extends well beyond NJ Transit. The Court established a clear national standard: where a state elects to operate through the corporate form, grants the entity authority to sue and be sued, and does not make itself legally liable for the entity’s judgments, immunity generally will not apply. Transit authorities, public benefit corporations, and other quasi-public agencies structured as corporations across the country will no longer be permitted to invoke the state’s dignity in court while disclaiming the state’s fiscal responsibility. More cases will now proceed past threshold immunity challenges and be resolved on their merits — the way the civil justice system is supposed to work.

    From a litigation standpoint, this ruling forecloses a major threshold defense that NJ Transit and similarly structured agencies had been deploying for years. Cases that were previously stayed or dismissed on immunity grounds may now be eligible to move forward. Attorneys handling NJ Transit injury cases should review prior dismissals to assess whether revival or refiling is possible under applicable statutes of limitations.

    What this ruling does not decide is also worth stating plainly. It does not determine that NJ Transit was at fault in these specific accidents. It does not guarantee any particular outcome for Colt or Galette. What it does is remove the procedural barrier that prevented their cases from being heard at all. The merits of each negligence claim — the duty NJ Transit owed, whether it breached that duty, and what damages resulted — will now be litigated in their respective courts.

    If you or a family member has been injured by an NJ Transit vehicle, this ruling is significant. You should speak with a qualified personal injury attorney in your state about your options, the evidence available in your case, and the applicable deadlines for filing a claim.

    • People injured by NJ Transit outside New Jersey can now sue in their home state courts
    • The ruling eliminates a major threshold immunity defense NJ Transit had been using to seek dismissal before the merits were ever reached
    • Transit authorities and quasi-public corporations nationwide face the same legal standard going forward
    • Prior cases dismissed on sovereign immunity grounds may be worth reviewing with an attorney
    • Injured individuals should act promptly because statutes of limitations still apply

    Conclusion

    The Supreme Court’s unanimous decision in Galette v. New Jersey Transit Corporation is a significant win for injured people across the northeastern corridor and for the principle of corporate accountability nationwide. By ruling that NJ Transit is a legally independent corporation — not an arm of New Jersey — the Court confirmed that accident victims in New York, Pennsylvania, and elsewhere have the right to pursue their claims in their own courts. The work of Sullivan Papain Block McManus Coffinas & Cannavo P.C. and the recognition extended by New York State Trial Lawyers Association President Andrew Finkelstein reflect how much this outcome meant to the broader plaintiff community — and to the ordinary people whose cases were being dismissed before a single fact was ever heard.

    The decision brings clarity to an area of law that had produced contradictory results from state to state and ensures that public corporations cannot use a sovereign immunity shield they were never entitled to claim. For anyone hurt by an NJ Transit vehicle outside New Jersey, the message from the Supreme Court is clear: your case deserves to be heard. Speaking with an experienced personal injury attorney as soon as possible is the most important step you can take.

    Sources:

    Galette v. New Jersey Transit Corporation, No. 24–1021, 607 U.S. ___ (March 4, 2026) — Supreme Court slip opinion (full text reviewed)

    SCOTUSblog, “Supreme Court rules that New Jersey Transit can be sued in other states” (March 4, 2026): 

    New York State Trial Lawyers Association, statement by President Andrew Finkelstein regarding Galette v. NJ Transit (March 4, 2026)

    Sullivan Papain Block McManus Coffinas & Cannavo P.C. — counsel for plaintiff in the New York proceedings; recognized for Supreme Court advocacy in this case

    New Jersey Public Transportation Act of 1979, N.J. Stat. §27:25–1 et seq.

    New Jersey Tort Claims Act, N.J. Stat. §§59:1–1, 59:1–3

    New Jersey Contractual Liability Act, N.J. Stat. §59:13–2

    Hess v. Port Authority Trans-Hudson Corporation, 513 U.S. 30 (1994)

    Regents of University of California v. Doe, 519 U.S. 425 (1997)

    Lewis v. Clarke, 581 U.S. 155 (2017)

    New Jersey Transit Corporation Annual Financial Report (Year Ended June 30, 2024): 

     

    Additional Articles

    Discover Next

    Insights from Experts

    Learn from industry experts about key cases, the business of law, and more insights that shape the future of trial law.

    Author